Insider: Mahadevia Ankit Director - Spero Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 703,294 | 0 | 703,294 |
| Value | $1,709,004.42 | $0.00 | $1,709,004.42 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/28/2025 | DDS | 6,572 | Direct | COM | $1.97 | $12,946.84 | 703,294 |
| 02/05/2025 | DDS | 13,959 | Direct | COM | $0.78 | $10,888.02 | 745,126 |
| 02/05/2025 | DDS | 55,260 | Direct | COM | $0.78 | $43,102.80 | 689,866 |
| 08/27/2024 | DDS | 5,912 | Direct | COM | $1.35 | $7,981.20 | 759,085 |
| 02/02/2024 | DDS | 63,795 | Direct | COM | $1.37 | $87,399.15 | 744,997 |
| 08/28/2023 | DDS | 9,040 | Direct | COM | $1.26 | $11,390.40 | 788,792 |
| 02/03/2023 | DDS | 12,286 | Direct | COM | $1.81 | $22,237.66 | 797,832 |
| 11/04/2020 | DDS | 7,370 | Direct | COM | $14.43 | $106,335.10 | 65,817 |
| 11/03/2020 | DDS | 2,137 | Direct | COM | $14.27 | $30,489.65 | 65,817 |
| 10/23/2020 | DDS | 20 | Direct | COM | $14.25 | $285.00 | 65,817 |
| 10/14/2020 | DDS | 105 | Direct | COM | $14.25 | $1,496.25 | 65,817 |
| 10/13/2020 | DDS | 14,367 | Direct | COM | $14.28 | $205,212.48 | 65,817 |
| 09/08/2020 | DDS | 774 | Direct | COM | $14.25 | $11,029.73 | 65,817 |
| 09/08/2020 | DDS | 774 | Direct | COM | $14.25 | $11,029.73 | 65,817 |
| 07/09/2020 | DDS | 2,293 | Direct | COM | $14.31 | $32,806.64 | 65,817 |
| 07/07/2020 | DDS | 754 | Direct | COM | $14.25 | $10,744.95 | 65,817 |
| 07/06/2018 | DDS | 100 | Direct | COM | $17.55 | $1,754.50 | 66,817 |
| 07/06/2018 | DDS | 400 | Direct | COM | $17.58 | $7,032.00 | 66,417 |
| 07/06/2018 | DDS | 500 | Direct | COM | $17.50 | $8,750.00 | 66,917 |
| 07/06/2018 | DDS | 200 | Direct | COM | $17.90 | $3,580.00 | 66,017 |
| 07/06/2018 | DDS | 200 | Direct | COM | $17.92 | $3,584.00 | 65,817 |
| 07/06/2018 | DDS | 100 | Direct | COM | $17.71 | $1,770.50 | 66,217 |
| 07/06/2018 | DDS | 100 | Direct | COM | $17.62 | $1,762.00 | 66,317 |
| 07/05/2018 | DDS | 3,076 | Direct | COM | $17.62 | $54,203.73 | 65,817 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research